Vitamin D Treatment in Hemodialysis patients

Evaluation of the effect of vitamin D deficiency treatment on hemoglobin levels in hemodialysis patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190107042264N4

Enrollment

Registered

2020-12-16

Start date

2020-06-21

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia in patients with End Stage Kidney Disease (ESRD). Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention group 1: This group Undergoes treatment with 50000 IU Pearl Vitamin D3 once weekly for 12 weeks. Intervention 2: Intervention group 2: This group Undergoes treatment with

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients Undergoing Hemodialysis at least once weekly due to ESRD Treatment with erythropoietin Serum 25-hydroxy vitamin D content less than 30 nanograms/milliliter

Exclusion criteria

Exclusion criteria: Serum 25-hydroxy vitamin D content more than 30 nanograms/milliliter

Design outcomes

Primary

Measure	Time frame
Serum Hemoglobin level. Timepoint: before intervention, 3 months after intervention. Method of measurement: Complete Blood Count.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahla Ahmadi Halili

Ahvaz University of Medical Sciences

ahmadihalili-sh@ajums.ac.ir+98 61 3222 2114

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026